Entero Healthcare Solutions Limited (NSE:ENTERO)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Pharmaceutical and Surgical Products	38.88B
Pharmaceutical and Surgical Products Growth	18.07%
Other	341.47M
Other Growth	383.39%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
India	39.22B
India Growth	18.85%